Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – The Lancet Invited Commentary: Studying the coagulopathy of COVID-19 – The Lancet   Commentary from the author on Twitter (thread – click for more) RECOVERY Publication: ASPIRIN(a widely used anti-platelet treatment in other settings) 14 892 patients hospitalised with COVID-19. […]

The post RECOVERY Trial: Aspirin as an add-on therapy did not reduce mortality in patients hospitalized with COVID-19. appeared first on Links Medicus.